Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

National Ophthalmic Genotyping and Phenotyping Network, Stage 3 - Expansion of DNA and Data Repositories for Rare Inherited Ophthalmic Diseases

NCT06491615 is registered in ClinicalTrials.gov with National Eye Institute (NEI) as lead sponsor.

NCT NCT06491615
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06491615 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
National Ophthalmic Genotyping and Phenotyping Network, Stage 3 - Expansion of DNA and Data Repositories for Rare Inherited Ophthalmic Diseases
Lead sponsor
National Eye Institute (NEI)
Phase
Observational
Overall status
Recruiting
Start date
July 12, 2024
Completion date
June 27, 2054
Enrollment
1,000 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

albinism, aniridia, best disease, blue-cone monochromacy, corneal dystrophy, hypopigmentation disorder, inherited ophthalmic diseases